Ohcanbohtosat - Sang-Cheul Oh
- Čájehuvvo 1 - 20 / 36
- Sirdás čuovvovaš siidui
-
1
-
2
-
3
How Does Inhibition of the Renin-Angiotensin System Affect the Prognosis of Advanced Gastric Cancer Patients Receiving Platinum-Based Chemotherapy? Dahkki Seung Tae Kim, Kyong Hwa Park, Sang Cheul Oh, Jae Hong Seo, Jun Suk Kim, Sang Won Shin, Yeul Hong Kim
Almmustuhtton 2012Artigo -
4
-
5
-
6
RUNX3 suppresses metastasis and stemness by inhibiting Hedgehog signaling in colorectal cancer Dahkki Bo Ram Kim, Yoo Jin Na, Jung Lim Kim, Yoon A Jeong, Seong Hye Park, Min Jee Jo, Soyeon Jeong, Sanghee Kang, Sang Cheul Oh, Dae-Hee Lee
Almmustuhtton 2019Artigo -
7
Ferroptosis‐inducing agents enhance TRAIL‐induced apoptosis through upregulation of death receptor 5 Dahkki Young‐Sun Lee, Dae‐Hee Lee, So Yeon Jeong, Seong Hye Park, Sang Cheul Oh, Yong Seok Park, Jian Yu, Haroon A. Choudry, David L. Bartlett, Yong J. Lee
Almmustuhtton 2018Artigo -
8
Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients Dahkki Keun‐Wook Lee, Sung Sook Lee, Sang-Bae Kim, Bo Hwa Sohn, Hyun‐Sung Lee, Hee-Jin Jang, Yun‐Yong Park, Scott Kopetz, Sung Soo Kim, Sang Cheul Oh, Ju–Seog Lee
Almmustuhtton 2014Artigo -
9
Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study Dahkki Eric Van Cutsem, Kei Muro, David Cunningham, G. Bodoky, Alberto Sobrero, Stefano Cascinu, Jaffer A. Ajani, Sang Cheul Oh, S. Al-Batran, Zev A. Wainberg, Sameera R. Wijayawardana, Symantha Melemed, D. Ferry, Rebecca R. Hozak, Atsushi Ohtsu
Almmustuhtton 2020Artigo -
10
Applying Computational Protein Design to Engineer Affibodies for Affinity-controlled Delivery of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor Dahkki Justin E. Svendsen, Madeleine R. Ford, Chandler L. Asnes, Sang Cheul Oh, Jonathan Dorogin, Karly M. Fear, Johnathan R. O’Hara-Smith, Lauren O. Chisholm, Sophia R. Phillips, Michael J. Harms, Parisa Hosseinzadeh, Marian H. Hettiaratchi
Almmustuhtton 2025Artigo -
11
Docosahexaenoic Acid Enhances Oxaliplatin-Induced Autophagic Cell Death via the ER Stress/Sesn2 Pathway in Colorectal Cancer Dahkki Soyeon Jeong, Dae Yeong Kim, Sanghee Kang, Hye Kyeong Yun, Jung Lim Kim, Bo Ram Kim, Seong Hye Park, Yoo Jin Na, Min Jee Jo, Yoon A Jeong, Bu Gyeom Kim, Dae-Hee Lee, Sang Cheul Oh
Almmustuhtton 2019Artigo -
12
Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer Dahkki Sang Cheul Oh, Yun‐Yong Park, Eun Sung Park, Jae Yun Lim, Soo Mi Kim, Sang-Bae Kim, Jong S. Kim, Sang Cheol Kim, In‐Sun Chu, J. Joshua Smith, R. Daniel Beauchamp, Timothy J. Yeatman, Scott Kopetz, Ju–Seog Lee
Almmustuhtton 2011Artigo -
13
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer Dahkki Stefano Cascinu, G. Bodoky, Kei Muro, Eric Van Cutsem, Sang Cheul Oh, Gunnar Folprecht, Sumitra Ananda, Gustavo Girotto, Zev A. Wainberg, María Luisa Limón Mirón, Jaffer A. Ajani, Ran Wei, Astra M. Liepa, Roberto Carlesi, Michael Emig, Atsushi Ohtsu
Almmustuhtton 2020Artigo -
14
Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated ga... Dahkki Salah‐Eddin Al‐Batran, Eric Van Cutsem, Sang Cheul Oh, G. Bodoky, Yoshifumi Shimada, Shuichi Hironaka, Naotoshi Sugimoto, O. N. Lipatov, T.-Y. Kim, David Cunningham, P. Rougier, Kei Muro, Astra M. Liepa, Kumari Chandrawansa, Michael Emig, Atsushi Ohtsu, H. Wilke
Almmustuhtton 2016Artigo -
15
Exposure-Response Analyses of Ramucirumab from Two Randomized, Phase III Trials of Second-line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer Dahkki Josep Tabernero, Atsushi Ohtsu, Kei Muro, Eric Van Cutsem, Sang Cheul Oh, G. Bodoky, Yasuhiro Shimada, Shuichi Hironaka, Jaffer A. Ajani, Jiří Tomášek, Howard Safran, Kumari Chandrawansa, Yanzhi Hsu, Michael Heathman, Azhar Khan, Lan Ni, Allen S. Melemed, Ling Gao, David Ferry, Charles S. Fuchs
Almmustuhtton 2017Artigo -
16
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data Dahkki Charles S. Fuchs, Kei Muro, Jiří Tomášek, Eric Van Cutsem, Y. Choi, Sang-Cheul Oh, Howard Safran, G. Bodoky, Ian Chau, Yasuhiro Shimada, Salah‐Eddin Al‐Batran, Rodolfo Passalacqua, Atsushi Ohtsu, Michael Emig, David Ferry, Kumari Chandrawansa, Yanzhi Hsu, Andreas Sashegyi, Astra M. Liepa, H. Wilke
Almmustuhtton 2017Artigo -
17
Genipin induces mitochondrial dysfunction and apoptosis via downregulation of Stat3/mcl-1 pathway in gastric cancer Dahkki Min Jee Jo, Soyeon Jeong, Hye Kyeong Yun, Dae Yeong Kim, Bo Ram Kim, Jung Lim Kim, Yoo Jin Na, Seong Hye Park, Yoon A Jeong, Bu Gyeom Kim, Hassan Ashktorab, Duane T. Smoot, Jun Young Heo, Jeongsu Han, Dae-Hee Lee, Sang Cheul Oh
Almmustuhtton 2019Artigo -
18
Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: A randomised phase III trial Dahkki Jin Won Kim, Sae Won Han, Y. Choi, Ik-Joo Chung, Jong Gwang Kim, Kyung Hee Lee, Keon Uk Park, Sun Kyung Baek, Sang Cheul Oh, Myung Ah Lee, Doyeun Oh, Byoungyong Shim, Joong Bae Ahn, Dongbok Shin, Jae‐Won Lee, Yeul Hong Kim
Almmustuhtton 2020Artigo -
19
Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, rando... Dahkki Tanios Bekaii‐Saab, Takuji Okusaka, David Goldstein, Do‐Youn Oh, Makoto Ueno, Tatsuya Ioka, Weijia Fang, Eric Anderson, Marcus Smith Noel, Michele Reni, Hye Jin Choi, Jonathan S. Goldberg, Sang Cheul Oh, Chung–Pin Li, Josep Tabernero, Jian Li, Emma Foos, Cindy Oh, Eric Van Cutsem
Almmustuhtton 2023Artigo -
20
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial Dahkki Zev A. Wainberg, Yoon‐Koo Kang, Keun‐Wook Lee, Shukui Qin, Kensei Yamaguchi, In‐Ho Kim, Anwaar Saeed, Sang Cheul Oh, Jin Li, Hacı Mehmet Türk, Alexandra Teixeira, Erika Hitre, Adrian Udrea, Giovanni Gerardo Cardellino, Raquel Guardeño Sanchez, Anita Zahlten‐Kumeli, Kate Taylor, Peter C. Enzinger
Almmustuhtton 2024Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Cancer
Medicine
Internal medicine
Oncology
Gastroenterology
Biology
Randomized controlled trial
Cancer research
Chemotherapy
Pathology
Alternative medicine
Placebo
Surgery
Biochemistry
Colorectal cancer
Confidence interval
Hazard ratio
Clinical endpoint
Chemistry
Gene
Cell biology
Genetics
Phases of clinical research
Apoptosis
Immunotherapy
Nivolumab
Oxaliplatin
Ramucirumab
Adenocarcinoma
Breast cancer